• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    'Graft-on-a-Chip' Built to Improve Vascular Graft Success

    Abbott Invests €440 in New Irish Facility

    FDA Approves Guardant Health's NGS-Based Companion Diagnostic

    Reflow Medical Completes DEEPER LIMUS Clinical Trial Enrollment

    NanoVibronix Strengthening its Supply Chain to Address Potential Delays
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Cooling and Melting the Pain Away

    What Are the Fundamentals of Go-To-Market Strategy in Medical Devices?

    Minding the Gap: How Harmonizing Quality Systems Pays Off

    Building Strong Partnerships Between Medtech and Surgeon-Learning Platforms

    Four Key Considerations for OEMs Transferring a Product Program
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Concise Engineering

    Cirtec Medical

    Arthur G. Russell Co. Inc., The

    Trademark Plastics Inc.

    JBC Technologies
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Medical Computing: COM Express Processes Real-Time Data at the Edge

    The Importance of Building Successful Supplier Relationships

    The Benefits of Outsourcing Innovation in Medtech Manufacturing

    Patching Healthcare Cybersecurity Risks in the Internet of Medical Things

    Leveraging Open Healthcare Data Standards to Improve Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Concise Engineering

    Cirtec Medical

    Arthur G. Russell Co. Inc., The

    Trademark Plastics Inc.

    JBC Technologies
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry

    ...

    Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry
    Related CONTENT
    • Connecting the Dots in Medical Device Outsourcing
    • Profiting from Philanthropy: The Business Case for Supporting Nonprofits
    • What’s ‘In’ for Manufacturing? (Hint: It’s Not Neon)
    • Quality Systems: It’s All Greek to Us
    • Transformative Testing: Addressing Patient Safety and Cybersecurity
    Dawn A. Lissy, President & Founder, Empirical07.30.19
    I’m generally an optimistic person. My outgoing voicemail greeting encourages every caller to “keep smiling!” My wardrobe is about 40 percent “Life is Good” apparel and I keep a daily gratitude journal.

    Despite this stockpile of good vibes and hopeful expectations, I have yet to find a ray of sunshine amid the brewing storm of regulatory change for medical devices in the European market. We’re less than a year away from the May 2020 implementation of the European Medical Device Regulation (MDR)—literally “mayday” for just about any company not already established with a CE mark or any firm large enough to have the resources to navigate the impending storm of reform.

    The MDR’s changes are complex and sweeping. The increased level of scrutiny, layers of oversight, and additional regulatory requirements are so deep and daunting, we’ve heard from several clients that they’re not even attempting to maintain CE marks, much less obtain new ones, until the dust settles three to five years from mayday. Startups have basically zero chance of breaking into the European market under the MDR. Christine Scifert and Ann Dunahoo, respectively executive vice president and principal consultant of MRC/X LLC, share my concerns that the changes will squeeze out potential breakthroughs by solo entrepreneurs and small businesses.

    “Small companies that have limited resources to gather the needed technical and clinical data are being negatively impacted by the MDR,” Dunahoo said.

    “The upfront cost for quality system inspections, including unannounced inspections and the cost of technical documentation submission is significant, so the small businesses have to weigh the cost against the expected EU market growth to determine if this is a market they pursue,” Scifert added.

    At Empirical, we’re seeing a shift in how our clients work to get their devices to market. It used to be common for smaller companies to first seek a CE mark and use it as a launching point for U.S. Food and Drug Administration (FDA) clearance and approval. But MDR is changing that. “I have more clients coming to me to get FDA clearance now because they can’t get into the European market. It used to be the other way around,” said Meredith May, vice president of Empirical Consulting. “Small companies with innovative plans aren’t going to even attempt to get into the EU. Now we see clients coming to the U.S.  to get a 510(k) because they don’t want to keep up [with MDR]. They’re going to let their CE mark lapse and focus all their sales in the U.S.”

    We’re also seeing extreme backlogs as companies work to beat deadlines to maintain their CE marks. It’s like a traffic jam in Houston as residents attempt a mass exodus from a Category 5 hurricane. May said she began advising clients to renew CE marks in 2016 to get ahead of the looming regulatory bottleneck. At that point, it was reasonable to expect it to take nine to 12 months to obtain a new CE mark. But due to the rush of companies trying to get ahead of the changes, the backlog for just renewing an existing mark has stretched to at least 18 months.

    Also affecting regulatory flow: Of the 58 notified bodies in the EU, only two are currently certified to MDR. That means no other notified body can start processing applications for devices to be sold under MDR. Notified bodies are also not processing any new applications for CE marks under the existing Medical Device Directive (MDD) because of that backlog.

    Back to that traffic jam: Once MDR takes effect, it’s going to get considerably larger. Backlog aside, the MDR requires new levels of documentation not just for new technology, but for devices that were historically granted CE marks.

    “Devices that were previously not covered by the MDD such as cleaning, disinfection, and sterilization are now covered by the MDR,” Dunahoo said. “Companies that have not previously documented technical documentation will now need to put together technical documentation compliant to the MDR. In some cases, these companies will have to contract with a notified body and obtain the appropriate quality certifications.”

    We have yet to get clear guidance on what those quality certifications will be, May added.

    “Generally speaking, every medical device has to have clinical evidence [under MDR],” May said. “They’re just starting out with the implants. Keep in mind—tongue depressors are medical devices. How do you establish clinical evidence for a tongue depressor?”

    Dunahoo and Scifert cite that need for clinical data as the single most significant change stemming from this new regulation. The current MDD allows historical equivalence even for Class III devices. But under MDR, a company needs full technical documentation, which only occurs when the company owns the equivalent device. 

    Post-market clinical follow-up studies to gather clinical data on the actual devices are going to be required, Dunahoo said, and that data will have to be more in-depth and continuously gathered.

    “The manufacturer will also have to document Periodic Safety Update Reports (PSUR), which will be posted on EUDAMED Class IIa—updated every two years—and Class IIb/III—updated annually,” Dunahoo said. “Additionally, a Summary of Safety and Clinical Performance (SSCP) for Class III and implantable devices will be required to be updated annually.”

    It’s a considerable burden, even for larger companies. May predicts the trend she’s seeing of companies eschewing the EU for the U.S. will grow exponentially. Two particularly concerning possible outcomes: The U.S. market is glutted with competition, which will drive down prices and profit margins, and the potential dearth of devices for European patients.

    “This is a legitimate crisis,” she said. “Imagine I need to get a knee replacement, and they can’t get artificial knees into the hospital where I live in Europe. We are facing an immediate shortage of medical devices.”

    It’s a crisis stemming from a long overdue revamp of processes and procedures to better protect patient health, which is the silver lining I find in this wall of storm clouds. As is too often the case, a knee-jerk reaction to course correct immediately threatens to capsize the ship. I appreciate that the FDA solicits feedback from the industry before implementing major revisions, and strongly disagree with the European Commissioner for Health and Food Safety’s June 14 announcement that next May’s deadline is “realistic and achievable.” If the EU had negotiated these changes with the industry, we could’ve achieved a much more reasonable set of regulations that protect both patients and the market.

    And that’s my humble opinion as a determined optimist. I’ll cling to the hope that reason will somehow prevail, and our industry will weather this storm because it’s anchored by the innovation and ingenuity that fuels it. 


    Dawn Lissy is a biomedical engineer, entrepreneur, and innovator. Since 1998, the Empirical family of companies (Empirical Testing Corp., Empirical Consulting, LLC, and Empirical Machine, LLC) has operated under Lissy’s direction. Empirical offers the full range of regulatory and quality systems consulting, testing, small batch and prototype manufacturing, and validations services to bring a medical device to market. Empirical is very active within standards development organization ASTM International and has one of the widest scopes of test methods of any accredited independent lab in the United States. Because Lissy was a member of the U.S. Food and Drug Administration’s Entrepreneur-in-Residence program, she has first-hand, in-depth knowledge of the regulatory landscape. Lissy holds an inventor patent for the Stackable Cage System for corpectomy and vertebrectomy. Her M.S. in biomedical engineering is from The University of Akron, Ohio. 
    Related Searches
    • u.s. food and drug administration
    • biomedical
    • first
    • system
    Suggested For You
    Connecting the Dots in Medical Device Outsourcing Connecting the Dots in Medical Device Outsourcing
    Profiting from Philanthropy: The Business Case for Supporting Nonprofits Profiting from Philanthropy: The Business Case for Supporting Nonprofits
    What’s ‘In’ for Manufacturing? (Hint: It’s Not Neon) What’s ‘In’ for Manufacturing? (Hint: It’s Not Neon)
    Quality Systems: It’s All Greek to Us Quality Systems: It’s All Greek to Us
    Transformative Testing: Addressing Patient Safety and Cybersecurity Transformative Testing: Addressing Patient Safety and Cybersecurity
    Why Big Companies With Internal Labs Should Outsource Testing Why Big Companies With Internal Labs Should Outsource Testing

    Related Columns

    • Contract Manufacturing | Digital Health | Software & IT
      Connecting the Dots in Medical Device Outsourcing

      Connecting the Dots in Medical Device Outsourcing

      ...
      MPO Staff 07.30.19

    • Profiting from Philanthropy: The Business Case for Supporting Nonprofits

      Profiting from Philanthropy: The Business Case for Supporting Nonprofits

      ...
      Dawn A. Lissy, President & Founder, Empirical 06.13.19

    • 3D/Additive Manufacturing
      What’s ‘In’ for Manufacturing? (Hint: It’s Not Neon)

      What’s ‘In’ for Manufacturing? (Hint: It’s Not Neon)

      ...
      Dawn A. Lissy , President & Founder, Empirical 05.01.19


    • Software & IT
      Quality Systems: It’s All Greek to Us

      Quality Systems: It’s All Greek to Us

      ...
      Dawn A. Lissy, President & Founder, Empirical 04.03.19

    • R&D & Design | Software & IT | Testing
      Transformative Testing: Addressing Patient Safety and Cybersecurity

      Transformative Testing: Addressing Patient Safety and Cybersecurity

      With changing regulatory landscapes and requirements, testing providers are being asked to do more in terms of ensuring the safety of medical devices.
      Mark Crawford, Contributing Writer 03.07.19

    Loading, Please Wait..

    Breaking News
    • 'Graft-on-a-Chip' Built to Improve Vascular Graft Success
    • Abbott Invests €440 in New Irish Facility
    • FDA Approves Guardant Health's NGS-Based Companion Diagnostic
    • Reflow Medical Completes DEEPER LIMUS Clinical Trial Enrollment
    • NanoVibronix Strengthening its Supply Chain to Address Potential Delays
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Parylene Coatings for Medical Device Technologies
    • Nearshoring Trends in Medtech Manufacturing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    SONGWON Industrial Group Reports Strong Q2 Financial Results
    PPG Completes COLORFUL COMMUNITIES Project for Boys & Girls Clubs of Greater Houston
    Paul N. Gardner Now Offers Bacharach Sling Psychrometer
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    'Graft-on-a-Chip' Built to Improve Vascular Graft Success
    Abbott Invests €440 in New Irish Facility
    FDA Approves Guardant Health's NGS-Based Companion Diagnostic
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AskBio Appoints Clinical Ops Executives
    SpectrumX Partners With UK Contract Manufacturer
    GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Arkay Chairman Emeritus Howard Kaneff Has Died
    Nutricosmetics Market to Hit $13.7 Billion by 2030
    Estée Lauder Pledges 100% Electric Fleet of Vehicles by 2030
    Happi

    Latest Breaking News From Happi

    J&J To Stop Global Sales of Talc-Based Products by 2023
    Net Sales Increase 2% for Naples Soap Company in Second Quarter
    Net Revenue Down 12% for Grove Collaborative in Second Quarter
    Ink World

    Latest Breaking News From Ink World

    Heidelberg Enjoys Successful Start to 2022-23 Fiscal Year
    Mimaki Announces New LATAM Website
    Paul N. Gardner Offers Bacharach Sling Psychrometer
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Esko, Constantia Flexibles announce acquisitions and more
    Hybrid Software joins The Flexo Xperience Center
    Flexo Wash LLC and Mike Potter celebrate 20 years
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Focke & Co. to Host Destination: Your Hygiene Hub on August 31
    Exports Dominate Chinese Trade of Tissues, Hygiene Products and Wipes
    Freudenberg to Present Friction Inserts for Wind Energy
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Dental 3D Printing Market is Expanding 20% Annually
    Study Results Released for Abbott's Concussion Blood Test
    Bone Growth Stimulators Market to Top $3B by 2030
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    eMagin Corporation Announces 2Q 2022 Results
    Zebra Technologies’ Emission Reduction Targets Validated by SBTi
    Identiv Delivers Impressive 41% Year-over-Year Growth in RFID Business

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login